Craniopharyngioma – Basic Information

Go back

Craniopharyngioma is a rare, noncancerous brain tumor that grows near the pituitary gland and hypothalamus, typically causing hormone imbalances, vision problems, and headaches. While it can occur at any age, most cases are found in children between 5 and 14 years old or in adults between 50 and 74 years old.

Understanding Craniopharyngioma: A Rare Brain Tumor

Craniopharyngioma is a type of benign brain tumor, which means it is not cancerous and does not spread to other parts of the body. However, the word “benign” does not mean it is harmless. This tumor develops near the pituitary gland, a pea-sized structure at the base of the brain that produces hormones controlling many vital body functions, and the hypothalamus, another small but important brain region responsible for regulating body temperature, hunger, thirst, and sleep[1][2].

The tumor grows slowly over time, sometimes taking years before symptoms become noticeable. As it enlarges, it can press on nearby brain structures, including nerves responsible for vision, blood vessels, and the fluid-filled spaces in the brain called ventricles. This pressure is what causes many of the symptoms and complications associated with craniopharyngioma[3].

There are two main types of craniopharyngioma: adamantinomatous and papillary. Adamantinomatous craniopharyngioma can affect people of all ages but is more common in children. It often contains calcium deposits that can be seen on imaging scans. Papillary craniopharyngioma, on the other hand, almost always occurs in adults and is typically more solid in structure without calcium deposits[2][5].

How Common Is Craniopharyngioma?

Craniopharyngioma is quite rare. Each year, approximately 2 people per 1 million are diagnosed with this condition. To put this in perspective, only about 600 people in the entire United States receive a craniopharyngioma diagnosis in a given year[2][10].

The condition shows a distinct pattern in when it tends to appear. Most cases are diagnosed in one of two age groups: children aged 5 to 14 years and adults aged 50 to 74 years. While adamantinomatous types can appear at any age, papillary subtypes are almost exclusively found in adults[2][3].

In the broader picture of brain tumors, craniopharyngiomas account for about 1.1 percent of all noncancerous brain tumors. Despite their rarity, they are particularly important to understand because of their location near critical brain structures and the significant impact they can have on a person’s health and quality of life[11].

What Causes Craniopharyngioma?

The exact cause of craniopharyngioma is not fully understood. Scientists know that it begins when cells near the pituitary gland develop changes in their DNA, which is the genetic material that provides instructions for how cells should behave. In healthy cells, DNA tells them when to grow, when to divide, and when to die. But when these instructions become faulty, cells can grow out of control and form a tumor[1].

Researchers have identified specific genetic changes associated with craniopharyngioma. In the papillary type, many tumors have a mutation in a gene called BRAF, specifically the BRAF V600E mutation. This discovery has been important because it has led to the development of targeted treatments that can specifically block the effects of this mutation[10][20].

The adamantinomatous type involves a different pathway. These tumors often have changes in the CTNNB1 gene, which produces a protein called beta-catenin. This protein is part of a cellular signaling system that helps control cell growth and development. When this system malfunctions, it can lead to uncontrolled cell growth and tumor formation[9].

It is important to note that craniopharyngioma is not contagious and cannot be passed from one person to another. There is also no evidence that lifestyle factors such as diet, exercise, or environmental exposures cause these tumors to develop[1].

Risk Factors

Unlike many other medical conditions, craniopharyngioma does not have clear risk factors that have been identified. This means there are no known behaviors, exposures, or conditions that increase a person’s chances of developing this tumor. The genetic changes that lead to craniopharyngioma appear to happen randomly rather than being inherited from parents or triggered by external factors[1].

Age is the only demographic factor that shows a pattern, with the condition being most commonly diagnosed in two distinct age groups: children between 5 and 14 years old and adults between 50 and 74 years old. However, this is more of a description of when the tumor typically appears rather than a true risk factor that causes the condition[2].

There is no evidence that craniopharyngioma runs in families or is more common in certain ethnic or racial groups. The rarity of the condition has made it difficult for researchers to identify patterns that might point to specific risk factors. This lack of known risk factors also means there are no specific preventive measures that can be taken to avoid developing craniopharyngioma[1].

Symptoms and How They Affect Daily Life

The symptoms of craniopharyngioma develop gradually as the tumor grows and begins to press on nearby brain structures. Because the tumor is located near the pituitary gland, hypothalamus, and optic nerves, many symptoms relate to the disruption of these important structures[1][2].

Headaches are one of the most common symptoms, often occurring in the morning. These headaches result from increased pressure inside the skull, which can worsen when lying down overnight. The pressure builds up because the tumor may block the normal flow of cerebrospinal fluid, the clear liquid that surrounds and cushions the brain and spinal cord[1][11].

Vision problems are another major concern. The optic nerves, which carry visual information from the eyes to the brain, pass very close to where craniopharyngiomas grow. When the tumor presses on these nerves, it can cause blurred vision, loss of peripheral vision (the ability to see things to the side), or progressive vision loss over time. Sometimes these changes happen so gradually that people do not notice them immediately[1][2].

Hormone-related symptoms are particularly common because of the tumor’s effect on the pituitary gland. In children, this can mean slowed growth, making them shorter than expected for their age, or delayed puberty. Parents might notice that their child is not keeping up with peers in height or that developmental milestones are occurring later than usual[1][2].

⚠️ Important
In children, symptoms like squinting, constant thirst, and falling behind siblings in height can be early warning signs of craniopharyngioma. While these symptoms can have many other explanations, they should be evaluated by a doctor, especially if they occur together or persist over time. Early detection can make a significant difference in treatment outcomes.

Adults may experience fatigue, low energy levels, weight gain, and sexual dysfunction. Women might have irregular menstrual periods or stop menstruating altogether, a condition called amenorrhea. Men might have difficulty achieving erections. Both men and women can experience decreased interest in sex[2][7].

Excessive thirst and frequent urination can occur when the tumor affects the production of a hormone that helps the kidneys regulate water balance in the body. This condition, called diabetes insipidus, is different from the more common diabetes mellitus and specifically relates to water balance rather than blood sugar[1][7].

Other symptoms can include nausea and vomiting, especially in the morning, unusual sleepiness or fatigue, memory problems, difficulty walking or maintaining balance, and changes in personality or behavior. Weight gain is also common, particularly in children. These varied symptoms can sometimes make diagnosis challenging, as they can be mistaken for other conditions[1][2].

Prevention: What Can Be Done?

Unfortunately, there are currently no known ways to prevent craniopharyngioma from developing. Because the exact cause of these tumors is not fully understood and there are no identified risk factors that can be modified through lifestyle changes or medical interventions, preventive strategies do not exist[1].

There are no vaccines, dietary supplements, or lifestyle modifications that have been shown to reduce the risk of developing craniopharyngioma. The genetic changes that lead to tumor formation appear to occur randomly and are not influenced by factors within a person’s control[1].

However, early detection can improve outcomes. Being aware of the symptoms, especially in children, and seeking medical attention when concerning signs appear can lead to earlier diagnosis. Parents should pay attention if their child begins squinting frequently, is constantly thirsty, seems to be growing much more slowly than siblings or peers, or complains of persistent headaches[16].

Regular medical check-ups provide opportunities for doctors to identify unusual symptoms or developmental delays that might warrant further investigation. While these check-ups cannot prevent craniopharyngioma, they can help catch it earlier, which may make treatment more manageable[13].

How Craniopharyngioma Changes Normal Body Functions

Understanding what happens in the body when craniopharyngioma develops can help explain why this condition causes such varied symptoms. The tumor’s location near critical brain structures means that even though it grows slowly and is not cancerous, it can significantly disrupt normal body functions[3].

The pituitary gland, often called the “master gland,” produces multiple hormones that control other glands throughout the body. When a craniopharyngioma grows near this gland, it can compress it and interfere with hormone production. The gland might produce too little of certain hormones, leading to various hormone deficiencies[2].

Growth hormone deficiency occurs when the pituitary cannot produce enough of the hormone that controls growth and development. In children, this manifests as slower than normal growth rates and shorter stature. In adults, growth hormone deficiency can lead to reduced bone density, increased body fat, decreased muscle mass, and elevated cholesterol levels, which can affect heart health[2].

Gonadotropin deficiency affects the hormones that control reproductive function. In children and adolescents, this can delay or prevent puberty. In women, it can cause irregular or absent menstrual periods, reduced fertility, and premature menopause symptoms. In men, it can lead to low testosterone levels, reduced sperm production, erectile dysfunction, and decreased sex drive[2].

Adrenocorticotropic hormone (ACTH) deficiency affects the hormone that stimulates the adrenal glands to produce cortisol, a vital stress hormone. Without adequate cortisol, people may feel constantly tired and weak, lose their appetite and weight, and have difficulty responding to physical stress such as illness or surgery. This can be a serious condition requiring hormone replacement therapy[2].

The tumor can also affect the hypothalamus, which regulates appetite, sleep-wake cycles, body temperature, and emotions. Damage to the hypothalamus can lead to uncontrollable weight gain, sleep disturbances, temperature regulation problems, and mood changes including depression or anxiety[2][3].

Vision problems occur through a purely mechanical process. The optic chiasm, where the optic nerves from both eyes cross, sits just above the pituitary gland. As a craniopharyngioma grows upward, it can compress this structure, damaging the nerve fibers that carry visual information. This typically affects peripheral vision first, creating blind spots that gradually expand if the tumor continues to grow[2][11].

If the tumor grows large enough to block the flow of cerebrospinal fluid through the ventricles in the brain, it can cause a condition called hydrocephalus. This buildup of fluid increases pressure throughout the brain, leading to headaches, nausea, vomiting, and potentially more serious neurological problems if left untreated[3][11].

⚠️ Important
Even after successful tumor removal, many of the hormone-related problems caused by craniopharyngioma may persist. This is because the tumor may have permanently damaged the pituitary gland or hypothalamus. Most patients require lifelong hormone replacement therapy and regular monitoring by an endocrinologist to manage these ongoing needs.

The complex nature of how craniopharyngioma affects the body explains why treatment requires a team of specialists, including neurosurgeons to remove the tumor, endocrinologists to manage hormone problems, ophthalmologists to monitor and treat vision issues, and other healthcare professionals to address the various complications that can arise[3][5].

Ongoing Clinical Trials on Craniopharyngioma

  • A study to evaluate the effectiveness of semaglutide for treating obesity caused by craniopharyngioma in children aged 12 to 17 years.

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • A study of tovorafenib for children and young adults with newly diagnosed or recurrent craniopharyngioma

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany The Netherlands

References

https://www.mayoclinic.org/diseases-conditions/craniopharyngioma/symptoms-causes/syc-20581521

https://my.clevelandclinic.org/health/diseases/22989-craniopharyngioma

https://www.ncbi.nlm.nih.gov/books/NBK519027/

https://medicine.utah.edu/neurosurgery/divisions/pediatrics/specialties/tumor/craniopharyngioma

https://www.abta.org/tumor_types/craniopharyngioma/

https://www.mskcc.org/cancer-care/types/pituitary-tumors/craniopharyngiomas

https://www.cancerresearchuk.org/about-cancer/brain-tumours/types/craniopharyngioma

https://my.clevelandclinic.org/health/diseases/22989-craniopharyngioma

https://emedicine.medscape.com/article/1157758-treatment

https://www.cancer.gov/news-events/cancer-currents-blog/2023/craniopharyngioma-zelboraf-cotellic

https://braintumorcenter.ucsf.edu/condition/craniopharyngioma

https://pmc.ncbi.nlm.nih.gov/articles/PMC6668277/

https://www.mayoclinic.org/diseases-conditions/craniopharyngioma/diagnosis-treatment/drc-20581537

https://www.aaroncohen-gadol.com/en/patients/craniopharyngioma/survival/living-with-craniopharyngioma

https://www.abta.org/mindmatters/my-journey-with-a-craniopharyngioma-facing-lifes-curveballs-with-strength-and-faith/

https://braintumor.org/news/surviving-craniopharyngioma/

https://www.mayoclinic.org/diseases-conditions/craniopharyngioma/diagnosis-treatment/drc-20581537

https://braintumor.org/news/patients-and-care-partners-share-17-tips-from-their-brain-surgery-experience/

https://www.aaroncohen-gadol.com/en/patients/craniopharyngioma/survival/overview

https://www.cancer.gov/news-events/cancer-currents-blog/2023/craniopharyngioma-zelboraf-cotellic

https://together.stjude.org/en-us/conditions/cancers/craniopharyngioma.html

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Is craniopharyngioma a cancer?

No, craniopharyngioma is not cancer. It is classified as a benign (non-cancerous) tumor, which means it does not spread to other parts of the body. However, it can still cause serious health problems because of where it grows and the structures it affects near the pituitary gland and hypothalamus.

Will I need hormone replacement therapy after treatment?

Most people with craniopharyngioma will need some form of hormone replacement therapy, either because the tumor damaged the pituitary gland or because treatment affected it. This typically involves taking daily medications to replace hormones like thyroid hormone, cortisol, growth hormone, or sex hormones. Your endocrinologist will work with you to determine which hormones you need and adjust dosages over time.

How long does it take to recover from craniopharyngioma surgery?

Recovery time varies depending on the type of surgery and individual circumstances. Many patients spend several days in the hospital after surgery. Most people can return to normal activities within 4 to 6 weeks, though full recovery may take several months. Recovery also depends on managing hormone imbalances and other complications that may arise after surgery.

What is the survival rate for craniopharyngioma?

The survival rate for craniopharyngioma is generally very good. More than 90 percent of people with this tumor are alive five years after diagnosis. Because craniopharyngioma is not cancerous and does not spread, most people can live for many years with proper treatment and management of related health issues.

Can craniopharyngioma come back after treatment?

Yes, craniopharyngiomas can recur after treatment. About half of all surgically removed tumors grow back over time. This is why craniopharyngioma is treated as a chronic condition requiring long-term follow-up with regular imaging scans and medical check-ups to monitor for recurrence. If the tumor does return, additional surgery, radiation therapy, or other treatments may be needed.

🎯 Key takeaways

  • Craniopharyngioma is a rare, benign brain tumor that affects only about 2 people per million each year, but its location near vital brain structures makes it particularly impactful on health and quality of life.
  • Two main age groups are affected: children between 5 and 14 years old, and adults between 50 and 74 years old, with different tumor subtypes predominating in each group.
  • Common symptoms include headaches, vision changes, hormone imbalances, growth problems in children, and excessive thirst, though symptoms can take years to develop as the tumor grows slowly.
  • The cause of craniopharyngioma remains unknown, with no identified risk factors or preventive measures—the genetic changes leading to tumor formation appear to occur randomly.
  • Most patients require lifelong hormone replacement therapy after treatment because the tumor or its treatment often permanently damages the pituitary gland.
  • About half of all surgically removed craniopharyngiomas recur over time, making regular follow-up care and monitoring essential throughout life.
  • For some papillary craniopharyngiomas with BRAF mutations, targeted drug therapy offers a promising alternative to surgery, potentially avoiding the risks associated with operating near delicate brain structures.
  • Despite being classified as benign, survival rates are excellent—more than 90 percent of people are alive five years after diagnosis—and many live for decades with proper treatment and management.

Connected medications: